Category: biotech

.After antibody-drug conjugate (ADC) expert Seagen was sold to Pfizer last year for a monstrous $43 billion, previous CEO David Epstein said he was seeking

.Amidst the genetic medications arms ethnicity, Front runner Pioneering is unveiling a brand new provider to aid biotechs tweak the preciseness of their treatments.The venture

.Strong Biotech Associate Editor Gabrielle Masson presented the 2024 lesson of Strong 15 victors on the flooring of the Stock market on Wednesday.Masson showed up

.Allow’s dive into a discussion with Ayla Ellison, Tough Biotech Managing Editor and also Michelle Benz as they cover the highlights as well as pleasure

.FibroGen is substantially restructuring its organization, giving up 75% of its united state team and ceasing financial investment in its lead candidate in reaction to

.After F2G’s 1st attempt to get a brand-new training class of antifungal to market was actually derailed by the FDA, the U.K.-based biotech has actually

.The FDA has carried out a partial hang on a period 3 non-small cell bronchi cancer cells practice run by BioNTech as well as OncoC4

.The FDA has positioned Kezar Life Sciences’ lupus test on hold after the biotech hailed 4 deaths during the course of the stage 2b research.Kezar

.After pushing back the choice meeting for Applied Rehabs’ metabolic disorder medicine govorestat, the FDA has actually currently decided that an intended advisory committee appointment

.For Lykos Therapeutics and also the company’s potential MDMA-assisted treatment for trauma (POST-TRAUMATIC STRESS DISORDER), the favorites only maintain coming..Previously this month, Lykos was hit